Utsunomiya T, Sumioki H, Korenaga S, Matsuoka K, Korenga M, Kadota T
Department of Obstetrics and Gynecology, Kyushu University, Beppu.
Nihon Sanka Fujinka Gakkai Zasshi. 1988 Apr;40(4):459-66.
In forty-six sterile women, endometriosis externa was diagnosed and classified laparoscopically. 21 patients were treated with Gestrinone 5mg-10mg/week and 25 patients were treated with Danazol 300mg-400mg/day for 6 months. The effects of these hormonal treatments were evaluated by second-look laparoscopy according to adhesion severity, number of blueberry spots and chocolate cyst size, as well as dysmenorrhea and other complaints. The results were as follows; 1) Dysmenorrhea was relieved in 60.0% of the Gestrinone-treated group and 45.5% of the Danazol group. 2) Adhesion was weakened or partially separated spontaneously in 66.7% of the Gestrinone group and 63.6% of the Danazol group. 3) Blueberry spots decreased in number or paled in 61.9% of the Gestrinone group and 75.0% of the Danazol group. 4) Chocolate cyst size became smaller in 60.0% of the Gestrinone group and 77.8% of the Danazol group. 5) Peritoneal fluid volume was not decreased after the hormonal treatments but the prostaglandin E2 concentration in peritoneal fluid was decreased (p less than 0.05) after Gestrinone therapy. 6) The patients complained of some side effects, liver function especially was disturbed in 48.0% of the Danazol group and 9.5% of the Gestrinone group. Hoarseness was complained of in 33.3% of the Gestrinone group and 12.0% of the Danazol group. 7) Finally, 23.8% of the Gestrinone group and 28.0% of the Danazol group conceived after the hormonal treatments.
对46名不育女性进行腹腔镜检查,诊断并分类外部子宫内膜异位症。21名患者接受每周5mg - 10mg炔诺酮治疗,25名患者接受每日300mg - 400mg达那唑治疗,疗程6个月。通过二次腹腔镜检查,根据粘连严重程度、蓝莓样斑点数量、巧克力囊肿大小以及痛经和其他症状,评估这些激素治疗的效果。结果如下:1)炔诺酮治疗组60.0%的患者痛经得到缓解,达那唑组为45.5%。2)炔诺酮组66.7%的患者粘连减轻或部分自发分离,达那唑组为63.6%。3)炔诺酮组61.9%的患者蓝莓样斑点数量减少或变淡,达那唑组为75.0%。4)炔诺酮组60.0%的患者巧克力囊肿变小,达那唑组为77.8%。5)激素治疗后腹腔液体积未减少,但炔诺酮治疗后腹腔液中前列腺素E2浓度降低(p < 0.05)。6)患者出现一些副作用,达那唑组48.0%的患者肝功能受到影响,炔诺酮组为9.5%。炔诺酮组33.3%的患者出现声音嘶哑,达那唑组为12.0%。7)最后,炔诺酮组23.8%的患者和达那唑组28.0%的患者在激素治疗后怀孕。